跳到正文
原文
Endpoints News 生物医药· ENDPOINTS·· 2026-10-01AI 评分19

United Therapeutics 赢得诉讼;BMS 获批 Camzyos 儿科适应症

United Therapeutics' legal victory; BMS' Camzyos approved for kids

AI 导读

United Therapeutics 在联邦法院赢得法律胜利。BMS 的 Camzyos 获批用于儿科患者。新闻还包括 Novo、Nektar 等企业动态。

正文

Plus news about No­vo, Nek­tar, Min­dRank, Mab­well Bio­science, Atara Bio­ther­a­peu­tics, Pierre Fab­re, Monte Rosa and Sko­pos Bio.

Unit­ed Ther­a­peu­tics wins court bat­tle: A fed­er­al court …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

来源:Endpoints News 生物医药 · endpoints.news